Vir Biotechnology’s sidelined hepatitis B candidate, designed to serve as a “functional cure,” has failed to achieve the ...

Vir Bio (VIR) reveals 24-week post-end-of-treatment data from a mid-stage trial for its Hep B therapy developed with Xencor ...

ADMA Biologics ADMA reported lower-than-expected results for the first quarter. Adjusted earnings per share of 14 cents missed the Zacks Consensus Estimate of 16 cents. Revenues of $114.8 million (up ...

ADMA Biologics ADMA is scheduled to report first-quarter 2025 results on May 7, after market close. The Zacks Consensus ...

While antibiotics given in the first week of life reduce vaccine responses at 15 months, probiotics might counteract these ...

Functional cure, defined as durable hepatitis B surface antigen (HBsAg) and hepatitis B virus (HBV) DNA titers below the lower limit of detection (LLOD), is associated with better clinical outcomes of ...

H-E-B is giving away 274,000 free reusable bags on Tuesday only, starting at 8 a.m. The Earth Day bags are available not just at H-E-B, but also at Central Market, Mi Tienda and Joe V's Smart Shop ...

Hepatitis B is a highly infectious liver disease caused by the Hepatitis B virus (HBV) and is primarily transmitted through infected blood, bodily fluids, or childbirth. Although many cases are acute ...